T
Tyrone D. Cannon
Researcher at Yale University
Publications - 571
Citations - 44590
Tyrone D. Cannon is an academic researcher from Yale University. The author has contributed to research in topics: Psychosis & Schizophrenia. The author has an hindex of 105, co-authored 535 publications receiving 39587 citations. Previous affiliations of Tyrone D. Cannon include University of Pennsylvania & University of California, Los Angeles.
Papers
More filters
Journal ArticleDOI
Cortical abnormalities in youth at clinical high-risk for psychosis: Findings from the NAPLS2 cohort.
Yoonho Chung,Dana M Allswede,Jean Addington,Carrie E. Bearden,Kristin S. Cadenhead,Barbara A. Cornblatt,Daniel H. Mathalon,Thomas H. McGlashan,Diana O. Perkins,Larry J. Seidman,Ming T. Tsuang,Elaine F. Walker,Scott W. Woods,Sarah McEwen,Theo G.M. van Erp,Tyrone D. Cannon +15 more
TL;DR: Results are consistent with the view that neuroanatomical deviance manifesting in early adolescence marks vulnerability to a form of psychosis presenting with poor premorbid adjustment, an earlier age of onset (generally prior to the age of 18 years), and poor long-term outcome.
Journal ArticleDOI
Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample
Andrea M. Auther,Andrea M. Auther,Kristin S. Cadenhead,Ricardo E. Carrión,Ricardo E. Carrión,Jean Addington,Carrie E. Bearden,Tyrone D. Cannon,Tom McGlashan,Diana O. Perkins,Larry J. Seidman,Ming T. Tsuang,Elaine F. Walker,Scott W. Woods,Barbara A. Cornblatt,Barbara A. Cornblatt +15 more
TL;DR: This data indicates that cannabis use has been examined as a predictor of psychosis in clinical high‐risk (CHR) samples, but little is known about the impact of other substances on this relationship.
Journal ArticleDOI
Antipsychotic drug treatment in the prodromal phase of schizophrenia.
TL;DR: Safety and tolerability of short-term treatment with a low dose of risperidone was evaluated in adolescents with prodromal symptoms and a family history of schizophrenia, finding changes that achieved statistical significance despite the small group sizes.
Journal ArticleDOI
Apolipoprotein E genotype in schizophrenia: frequency, age of onset, and neuropathologic features.
Steven E. Arnold,Eun-Jeong Joo,M. G. Martinoli,N. Roy,John Q. Trojanowski,Raquel E. Gur,Tyrone D. Cannon,R. A. Price +7 more
TL;DR: An examination of ApoE in relation to clinical and neurobiological features of schizophrenia suggests that it modifies the phenotypic expression of the disease.
Journal ArticleDOI
Elucidating continuities and discontinuities between schizotypy and schizophrenia in the nervous system.
TL;DR: The research reviewed in this paper, making use of family and twin designs, suggests that certain neural system deficits in schizophrenia are reflective of an inherited diathesis to the disorder, while others result from the interacting influences of genetic factors and particular types of biologically disruptive environmental events.